{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:53:15Z","timestamp":1793364795330,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T00:00:00Z","timestamp":1410307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s12035-014-8886-3","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T06:08:50Z","timestamp":1410242930000},"page":"533-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Beta-Amyloid Precursor Protein (\u03b2APP) Processing in Alzheimer\u2019s Disease (AD) and Age-Related Macular Degeneration (AMD)"],"prefix":"10.1007","volume":"52","author":[{"given":"Yuhai","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surjyadipta","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sambamurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Lukiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,10]]},"reference":[{"key":"8886_CR1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0962-8924(98)01363-4","volume":"8","author":"DJ Selkoe","year":"1998","unstructured":"Selkoe DJ (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer\u2019s disease. Trends Cell Biol 8:447\u2013453","journal-title":"Trends Cell Biol"},{"key":"8886_CR2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1582-4934.2011.01507.x","volume":"16","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Interaction between pathogenic proteins in neurodegenerative disorders. J Cell Mol Med 16:1166\u20131183","journal-title":"J Cell Mol Med"},{"key":"8886_CR3","doi-asserted-by":"publisher","unstructured":"Yang X, Sun GY, Eckert GP, Lee JC (2014) Cellular membrane fluidity in amyloid precursor protein processing. Mol Neurobiol. doi: 10.1007\/s12035-014-8652-6","DOI":"10.1007\/s12035-014-8652-6"},{"key":"8886_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fphys.2013.00024","volume":"4","author":"WJ Lukiw","year":"2013","unstructured":"Lukiw WJ (2013) Alzheimer\u2019s disease (AD) as a disorder of the plasma membrane. Front Physiol 4:24. doi: 10.3389\/fphys.2013.00024","journal-title":"Front Physiol"},{"key":"8886_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12264-013-1422-z","volume":"30","author":"E Dorey","year":"2014","unstructured":"Dorey E, Chang N, Liu QY, Yang Z, Zhang W (2014) Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer\u2019s disease. Neurosci Bull 30:317\u2013330","journal-title":"Neurosci Bull"},{"key":"8886_CR6","first-page":"120","volume":"1","author":"GG Glenner","year":"1981","unstructured":"Glenner GG, Henry JH, Fujihara S (1981) Congophilic angiopathy in the pathogenesis of Alzheimer\u2019s degeneration. Ann Pathol 1:120\u2013129","journal-title":"Ann Pathol"},{"key":"8886_CR7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2012.08.020","volume":"425","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 425:534\u2013539","journal-title":"Biochem Biophys Res Commun"},{"key":"8886_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(89)90214-1","volume":"94","author":"GG Glenner","year":"1989","unstructured":"Glenner GG, Murphy MA (1989) Amyloidosis of the nervous system. J Neurol Sci 94:1\u201328","journal-title":"J Neurol Sci"},{"key":"8886_CR9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/01.wnl.0000338626.93425.74","volume":"72","author":"O Buda","year":"2009","unstructured":"Buda O, Arsene D, Ceausu M, Dermengiu D, Curca GC (2009) Georges Marinesco and the early research in neuropathology. Neurology 72:88\u201391","journal-title":"Neurology"},{"key":"8886_CR10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"A Alzheimer","year":"1995","unstructured":"Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR (1995) An English translation of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde\u201d. Clin Anat 8:429\u2013431","journal-title":"Clin Anat"},{"key":"8886_CR11","first-page":"241","volume":"46","author":"RA Armstrong","year":"2008","unstructured":"Armstrong RA (2008) Spatial correlations between beta-amyloid (Abeta) deposits and blood vessels in familial Alzheimer\u2019s disease. Folia Neuropathol 46:241\u2013248","journal-title":"Folia Neuropathol"},{"key":"8886_CR12","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2174\/156802607782507402","volume":"7","author":"S Furumoto","year":"2007","unstructured":"Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, Kudo Y (2007) Recent advances in the development of amyloid imaging agents. Curr Top Med Chem 7:1773\u20131789","journal-title":"Curr Top Med Chem"},{"key":"8886_CR13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.semnuclmed.2012.07.001","volume":"42","author":"CA Mathis","year":"2012","unstructured":"Mathis CA, Mason NS, Lopresti BJ, Klunk WE (2012) Development of positron emission tomography \u03b2-amyloid plaque imaging agents. Semin Nucl Med 42:423\u2013432","journal-title":"Semin Nucl Med"},{"key":"8886_CR14","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1167\/iovs.03-1083","volume":"45","author":"I Lengyel","year":"2004","unstructured":"Lengyel I, Tufail A, Hosaini HA, Luthert P, Bird AC, Jeffery G (2004) Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. Invest Ophthalmol Vis Sci 45:2886\u20132892","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8886_CR15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pneurobio.2011.05.011","volume":"95","author":"E Buschini","year":"2011","unstructured":"Buschini E, Piras A, Nuzzi R, Vercelli A (2011) Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol 95:14\u201325","journal-title":"Prog Neurobiol"},{"key":"8886_CR16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12:383\u2013388","journal-title":"Trends Pharmacol Sci"},{"key":"8886_CR17","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.febslet.2013.05.010","volume":"587","author":"NN Nalivaeva","year":"2013","unstructured":"Nalivaeva NN, Turner AJ (2013) The amyloid precursor protein: a biochemical enigma in brain development, function and disease. FEBS Lett 587:2046\u20132054","journal-title":"FEBS Lett"},{"key":"8886_CR18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.febslet.2013.12.038","volume":"588","author":"P Sorrentino","year":"2014","unstructured":"Sorrentino P, Iuliano A, Polverino A, Jacini F, Sorrentino G (2014) The dark sides of amyloid in Alzheimer\u2019s disease pathogenesis. FEBS Lett 588:641\u2013652","journal-title":"FEBS Lett"},{"key":"8886_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.preteyeres.2011.02.004","volume":"30","author":"K Ohno-Matsui","year":"2011","unstructured":"Ohno-Matsui K (2011) Parallel findings in age-related macular degeneration and Alzheimer\u2019s disease. Prog Retin Eye Res 30:217\u2013238","journal-title":"Prog Retin Eye Res"},{"key":"8886_CR20","doi-asserted-by":"publisher","unstructured":"Huang EJ, Wu SH, Lai CH, Kuo CN, Wu PL, Chen CL, Chen CY, King YC, Wu PC (2014) Prevalence and risk factors for age-related macular degeneration in the elderly Chinese population in south-western Taiwan: the Puzih eye study. Eye (Lond). doi: 10.1038\/eye.2014.55","DOI":"10.1038\/eye.2014.55"},{"key":"8886_CR21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3346\/jkms.2012.27.5.537","volume":"27","author":"BG Moon","year":"2012","unstructured":"Moon BG, Joe SG, Hwang JU, Kim HK, Choe J, Yoon YH (2012) Prevalence and risk factors of early-stage age-related macular degeneration in patients examined at a health promotion center in Korea. J Korean Med Sci 27:537\u2013541","journal-title":"J Korean Med Sci"},{"key":"8886_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/1471-2164-14-290","volume":"14","author":"WG Tharp","year":"2013","unstructured":"Tharp WG, Sarkar IN (2013) Origins of amyloid-\u03b2. BMC Genomics 14:290. doi: 10.1186\/1471-2164-14-290","journal-title":"BMC Genomics"},{"key":"8886_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2005.12.150","volume":"341","author":"Y Chen","year":"2006","unstructured":"Chen Y, Tang BL (2006) The amyloid precursor protein and postnatal neurogenesis\/neuroregeneration. Biochem Biophys Res Commun 341:1\u20135","journal-title":"Biochem Biophys Res Commun"},{"key":"8886_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","volume":"12","author":"VW Chow","year":"2010","unstructured":"Chow VW, Mattson MP, Wong PC, Gleichmann M (2010) An overview of APP processing enzymes and products. Neuromol Med 12:1\u201312","journal-title":"Neuromol Med"},{"key":"8886_CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/0-387-23226-5_11","volume":"38","author":"C Exley","year":"2005","unstructured":"Exley C (2005) The aluminum-amyloid cascade hypothesis of Alzheimer\u2019s disease. Subcell Biochem 38:225\u2013234","journal-title":"Subcell Biochem"},{"key":"8886_CR26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3233\/JAD-121909","volume":"35","author":"JR Walton","year":"2013","unstructured":"Walton JR (2013) Aluminum involvement in the progression of Alzheimer\u2019s disease. J Alzheimers Dis 35:7\u201343","journal-title":"J Alzheimers Dis"},{"key":"8886_CR27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1023\/B:CEMN.0000022773.70722.b2","volume":"24","author":"TP Kruck","year":"2004","unstructured":"Kruck TP, Cui JG, Percy ME, Lukiw WJ (2004) Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum. Cell Mol Neurobiol 24:443\u2013459","journal-title":"Cell Mol Neurobiol"},{"key":"8886_CR28","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","volume":"337","author":"DR Crapper McLachlan","year":"1991","unstructured":"Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer\u2019s disease. Lancet 337:1304\u20131308","journal-title":"Lancet"},{"key":"8886_CR29","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jinorgbio.2011.08.001","volume":"105","author":"ME Percy","year":"2011","unstructured":"Percy ME, Kruck TP, Pogue AI, Lukiw WJ (2011) Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer\u2019s disease. J Inorg Biochem 105:1505\u20131512","journal-title":"J Inorg Biochem"},{"key":"8886_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fnagi.2014.00062.eCollection 2014","volume":"6","author":"S Bhattacharjee","year":"2014","unstructured":"Bhattacharjee S, Zhao Y, Hill JM, Percy ME, Lukiw WJ (2014) Aluminum and its potential contribution to Alzheimer\u2019s disease (AD). Front Aging Neurosci 6:62. doi: 10.3389\/fnagi.2014.00062.eCollection 2014","journal-title":"Front Aging Neurosci"},{"key":"8886_CR31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jinorgbio.2013.05.010","volume":"128","author":"PN Alexandrov","year":"2013","unstructured":"Alexandrov PN, Zhao Y, Jones BM, Bhattacharjee S, Lukiw WJ (2013) Expression of the phagocytosis-essential protein TREM2 is down-regulated by an aluminum-induced miRNA-34a. J Inorg Biochem 128:267\u2013269","journal-title":"J Inorg Biochem"},{"key":"8886_CR32","doi-asserted-by":"crossref","first-page":"11830","DOI":"10.1073\/pnas.192203399","volume":"99","author":"LV Johnson","year":"2002","unstructured":"Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH (2002) The Alzheimer\u2019s A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A 99:11830\u201311835","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8886_CR33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1172\/JCI25843","volume":"116","author":"V Luibl","year":"2006","unstructured":"Luibl V, Isas JM, Kayed R, Glabe CG, Langen R, Chen J (2006) Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest 116:378\u2013385","journal-title":"J Clin Invest"},{"key":"8886_CR34","first-page":"184","volume":"9","author":"T Dentchev","year":"2003","unstructured":"Dentchev T, Milam AH, Lee VM, Trojanowski JQ, Dunaief JL (2003) Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis 9:184\u2013190","journal-title":"Mol Vis"},{"key":"8886_CR35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.exer.2003.10.011","volume":"78","author":"DH Anderson","year":"2004","unstructured":"Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV (2004) Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res 78:243\u2013256","journal-title":"Exp Eye Res"},{"key":"8886_CR36","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3233\/JAD-2010-100210","volume":"20","author":"A Prakasam","year":"2010","unstructured":"Prakasam A, Muthuswamy A, Ablonczy Z, Greig NH, Fauq A, Rao KJ, Pappolla MA, Sambamurti K (2010) Differential accumulation of secreted AbetaPP metabolites in ocular fluids. J Alzheimers Dis 20:1243\u20131253","journal-title":"J Alzheimers Dis"},{"key":"8886_CR37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tox.2008.11.007","volume":"256","author":"OI Aruoma","year":"2009","unstructured":"Aruoma OI, Jen SS, Watts HR, George J, Gentleman SM, Anderson PJ, Jen LS (2009) Acute and chronic effects of intravitreally injected beta-amyloid on the neurotransmitter system in the retina. Toxicology 256:92\u2013100","journal-title":"Toxicology"},{"issue":"1","key":"8886_CR38","doi-asserted-by":"crossref","first-page":"e52982","DOI":"10.1371\/journal.pone.0052982","volume":"8","author":"MW Sieber","year":"2013","unstructured":"Sieber MW, Jaenisch N, Brehm M, Guenther M, Linnartz-Gerlach B, Neumann H (2013) Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke. PLoS ONE 8(1):e52982","journal-title":"PLoS ONE"},{"key":"8886_CR39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/WNR.0b013e32835fb6b0","volume":"24","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Bhattacharjee S, Jones BM, Dua P, Alexandrov PN, Hill JM, Lukiw WJ (2013) Regulation of TREM2 expression by an NF-\u043aB-sensitive miRNA-34a. Neuroreport 24:318\u2013323","journal-title":"Neuroreport"},{"key":"8886_CR40","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","volume":"34","author":"P Forabosco","year":"2013","unstructured":"Forabosco P, Ramasamy A, Trabzuni D, Walker R, Smith C, Bras J et al (2013) Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging 34:2699\u20132714","journal-title":"Neurobiol Aging"},{"key":"8886_CR41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","volume":"88","author":"SE Hickman","year":"2014","unstructured":"Hickman SE, El Khoury J (2014) TREM2 and the neuro-immunology of Alzheimer\u2019s disease. Biochem Pharmacol 88:495\u2013498","journal-title":"Biochem Pharmacol"},{"key":"8886_CR42","doi-asserted-by":"publisher","unstructured":"Yin RH, Yu JT, Tan L (2014) The role of SORL1 in Alzheimer\u2019s disease. Mol Neurobiol. doi: 10.1007\/s12035-014-8742-5 . PubMed PMID: 24833601","DOI":"10.1007\/s12035-014-8742-5"},{"key":"8886_CR43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/WNR.0b013e32801198bc","volume":"18","author":"JG Cui","year":"2007","unstructured":"Cui JG, Hill JM, Zhao Y, Lukiw WJ (2007) Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer\u2019s disease. Neuroreport 18:115\u2013119","journal-title":"Neuroreport"},{"key":"8886_CR44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archneur.65.3.329","volume":"65","author":"SC Waring","year":"2008","unstructured":"Waring SC, Rosenberg RN (2008) Genome-wide association studies in Alzheimer disease. Arch Neurol 65:329\u2013334","journal-title":"Arch Neurol"},{"key":"8886_CR45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJMe1213157","volume":"368","author":"H Neumann","year":"2013","unstructured":"Neumann H, Daly MJ (2013) Variant TREM2 as risk factor for Alzheimer\u2019s disease. N Engl J Med 368:182\u2013184","journal-title":"N Engl J Med"},{"key":"8886_CR46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/WNR.0b013e3283497334","volume":"22","author":"PN Alexandrov","year":"2011","unstructured":"Alexandrov PN, Pogue A, Bhattacharjee S, Lukiw WJ (2011) Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer\u2019s disease. Neuroreport 22:623\u2013627","journal-title":"Neuroreport"},{"key":"8886_CR47","first-page":"131","volume":"7","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Lukiw WJ (2013) TREM2 signaling, miRNA-34a and the extinction of phagocytosis. Front Cell Neurosci 7:131\u2013135","journal-title":"Front Cell Neurosci"},{"key":"8886_CR48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","volume":"88","author":"SE Hickman","year":"2013","unstructured":"Hickman SE, El Khoury J (2013) TREM2 and the neuroimmunology of Alzheimer\u2019s disease. Biochem Pharmacol 88:495\u2013498","journal-title":"Biochem Pharmacol"},{"key":"8886_CR49","first-page":"94","volume":"8","author":"BM Jones","year":"2014","unstructured":"Jones BM, Bhattacharjee S, Dua P, Hill JM, Zhao Y, Lukiw WJ (2014) Regulating amyloidogenesis through the natural triggering receptor expressed inmyeloid\/microglial cells 2 (TREM2). Front Cell Neurosci 8:94","journal-title":"Front Cell Neurosci"},{"key":"8886_CR50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12035-013-8424-8","volume":"48","author":"T Jiang","year":"2013","unstructured":"Jiang T, Yu JT, Zhu XC, Tan L (2013) TREM2 in Alzheimer\u2019s disease. Mol Neurobiol 48:180\u2013185","journal-title":"Mol Neurobiol"},{"key":"8886_CR51","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.12675","volume":"129","author":"E Dawkins","year":"2014","unstructured":"Dawkins E, Small DH (2014) Insights into the physiological function of the \u03b2-amyloid precursor protein: beyond Alzheimer\u2019s disease. J Neurochem 129:756\u2013769","journal-title":"J Neurochem"},{"key":"8886_CR52","first-page":"77","volume":"4","author":"WJ Lukiw","year":"2013","unstructured":"Lukiw WJ (2013) Antagonism of NF-\u03baB-up-regulated micro RNAs (miRNAs) in sporadic Alzheimer\u2019s disease (AD): anti-NF-\u03baB vs. anti-miRNA strategies. Front Genet 4:77\u201379","journal-title":"Front Genet"},{"key":"8886_CR53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fncel.2013.00133","volume":"7","author":"WJ Lukiw","year":"2013","unstructured":"Lukiw WJ (2013) Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer\u2019s disease (AD). Front Cell Neurosci 7:133","journal-title":"Front Cell Neurosci"},{"key":"8886_CR54","doi-asserted-by":"publisher","unstructured":"Lukiw WJ (2012) Amyloid beta (A\u03b2) peptide modulators and other current treatment strategies for Alzheimer\u2019s disease (AD). Expert Opin Emerg Drugs. doi: 10.1517\/14728214.2012.672559 . PubMed Central PMCID: PMC3399957","DOI":"10.1517\/14728214.2012.672559"},{"key":"8886_CR55","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","volume":"26","author":"C Priller","year":"2006","unstructured":"Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J (2006) Synapse formation and function is modulated by the amyloid precursor protein. J Neurosci 26:7212\u20137221","journal-title":"J Neurosci"},{"key":"8886_CR56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mcn.2012.07.009","volume":"51","author":"SH Tyan","year":"2012","unstructured":"Tyan SH, Shih AY, Walsh JJ, Maruyama H, Sarsoza F, Ku L, Eggert S, Hof PR, Koo EH, Dickstein DL (2012) Amyloid precursor protein (APP) regulates synaptic structure and function. Mol Cell Neurosci 51:43\u201352","journal-title":"Mol Cell Neurosci"},{"key":"8886_CR57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1755-5949.2010.00221.x","volume":"18","author":"HS Hoe","year":"2012","unstructured":"Hoe HS, Lee HK, Pak DT (2012) The upside of APP at synapses. CNS Neurosci Ther 18:47\u201356","journal-title":"CNS Neurosci Ther"},{"key":"8886_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","volume":"70","author":"PR Turner","year":"2003","unstructured":"Turner PR, O\u2019Connor K, Tate WP, Abraham WC (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70:1\u201332","journal-title":"Prog Neurobiol"},{"key":"8886_CR59","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1074\/jbc.M300629200","volume":"278","author":"KJ Barnham","year":"2003","unstructured":"Barnham KJ, McKinstry WJ, Multhaup G, Galatis D, Morton CJ, Curtain CC, Williamson NA, White AR, Hinds MG, Norton RS, Beyreuther K, Masters CL, ParkerMW CR (2003) Structure of the Alzheimer\u2019s disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. J Biol Chem 278:17401\u201317407","journal-title":"J Biol Chem"},{"key":"8886_CR60","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","volume":"142","author":"JA Duce","year":"2010","unstructured":"Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI (2010) Iron-export ferroxidase activity of \u03b2-amyloid precursor protein is inhibited by zinc in Alzheimer\u2019s disease. Cell 142:857\u2013867","journal-title":"Cell"},{"key":"8886_CR61","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bbrc.2007.10.021","volume":"364","author":"P Porayette","year":"2007","unstructured":"Porayette P, Gallego MJ, Kaltcheva MM, Meethal SV, Atwood CS (2007) Amyloid-beta precursor protein expression and modulation in human embryonic stem cells: a novel role for human chorionic gonadotropin. Biochem Biophys Res Commun 364:522\u2013527","journal-title":"Biochem Biophys Res Commun"},{"key":"8886_CR62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neulet.2008.11.046","volume":"450","author":"B Sheng","year":"2009","unstructured":"Sheng B, Song B, Zheng Z, Zhou F, Lu G, Zhao N, Zhang X, Gong Y (2009) Abnormal cleavage of APP impairs its functions in cell adhesion and migration. Neurosci Lett 450:327\u2013331","journal-title":"Neurosci Lett"},{"key":"8886_CR63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/156720512799361691","volume":"9","author":"Z Wang","year":"2012","unstructured":"Wang Z, Yang L, Zheng H (2012) Role of APP and A\u03b2 in synaptic physiology. Curr Alzheimer Res 9:217\u2013226","journal-title":"Curr Alzheimer Res"},{"key":"8886_CR64","first-page":"893","volume":"317","author":"D Allsop","year":"1989","unstructured":"Allsop D, Ikeda S, Glenner GG (1989) Evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer\u2019s disease. Prog Clin Biol Res 317:893\u2013902","journal-title":"Prog Clin Biol Res"},{"key":"8886_CR65","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","volume":"77","author":"MP Mattson","year":"1997","unstructured":"Mattson MP (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77:1081\u20131132","journal-title":"Physiol Rev"},{"key":"8886_CR66","doi-asserted-by":"crossref","first-page":"16532","DOI":"10.1073\/pnas.0607527103","volume":"103","author":"P Satpute-Krishnan","year":"2006","unstructured":"Satpute-Krishnan P, Degiorgis JA, Conley MP, Jang M, Bearer EL (2006) A peptide zipcode sufficient for anterograde transport within amyloid precursor protein. Proc Natl Acad Sci 103:16532","journal-title":"Proc Natl Acad Sci"},{"key":"8886_CR67","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbadis.2013.09.015","volume":"1842","author":"AM Swomley","year":"2013","unstructured":"Swomley AM, F\u00f6rster S, Keeney JT, Triplett J, Zhang Z, Sultana R, Butterfield DA (2013) Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim Biophys Acta 1842:1248\u20131257","journal-title":"Biochim Biophys Acta"},{"key":"8886_CR68","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/7562","volume":"6","author":"J Rossjohn","year":"1999","unstructured":"Rossjohn J, Cappai R, Feil SC, Henry A, McKinstry WJ, Galatis D, Hesse L, Multhaup G, Beyreuther K, Masters CL, Parker MW (1999) Crystal structure of theN-terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat Struct Biol 6:327\u2013331","journal-title":"Nat Struct Biol"},{"key":"8886_CR69","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1073\/pnas.111145298","volume":"98","author":"LS Goldstein","year":"2001","unstructured":"Goldstein LS (2001) Kinesin molecular motors: transport pathways, receptors, and human disease. Proc Natl Acad Sci U S A 98:6999\u20137003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8886_CR70","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2009-1148","volume":"18","author":"H Taru","year":"2009","unstructured":"Taru H, Suzuki T (2009) Regulation of the physiological function and metabolism of AbetaPP by AbetaPP binding proteins. J Alzheimers Dis 18:253\u2013265","journal-title":"J Alzheimers Dis"},{"key":"8886_CR71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pneurobio.2013.10.004","volume":"112","author":"S Ghavami","year":"2014","unstructured":"Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, Hashemi M, Owji AA, \u0141os MJ (2014) Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol 112:24\u201349","journal-title":"Prog Neurobiol"},{"key":"8886_CR72","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbapap.2012.07.017","volume":"1834","author":"T M\u00fcller","year":"2013","unstructured":"M\u00fcller T, Schr\u00f6tter A, Loosse C, Pfeiffer K, Theiss C, Kauth M, Meyer HE, Marcus K (2013) A ternary complex consisting of AICD, FE65, and TIP60 down-regulates stathmin1. Biochim Biophys Acta 1834:387\u2013394","journal-title":"Biochim Biophys Acta"},{"key":"8886_CR73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2011.05.044","volume":"499","author":"YY Li","year":"2011","unstructured":"Li YY, Cui JG, Dua P, Pogue AI, Bhattacharjee S, Lukiw WJ (2011) Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci Lett 499:109\u2013113","journal-title":"Neurosci Lett"},{"key":"8886_CR74","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.expneurol.2011.11.022","volume":"235","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ (2012) NF-\u043aB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp Neurol 235:484\u2013490","journal-title":"Exp Neurol"},{"key":"8886_CR75","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1097\/00001756-200409150-00006","volume":"15","author":"JG Cui","year":"2004","unstructured":"Cui JG, Fraser PE, St George-Hyslop P, Westaway D, Lukiw WJ (2004) Potential roles for presenilin-1 in oxygen sensing and in glial-specific gene expression. Neuroreport 15:2025\u20132028","journal-title":"Neuroreport"},{"key":"8886_CR76","doi-asserted-by":"crossref","first-page":"e15816","DOI":"10.1371\/journal.pone.0015816","volume":"6","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Calon F, Julien C, Winkler JW, Petasis NA, Lukiw WJ, Bazan NG (2011) Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR\u03b3-mediated mechanisms in Alzheimer\u2019s disease models. PLoS ONE 6:e15816","journal-title":"PLoS ONE"},{"key":"8886_CR77","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","volume":"56","author":"C Skerka","year":"2013","unstructured":"Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT (2013) Complement factor H related proteins (CFHRs). Mol Immunol 56:170\u2013180","journal-title":"Mol Immunol"},{"key":"8886_CR78","doi-asserted-by":"publisher","unstructured":"Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A (2014) Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet. doi: 10.1146\/annurev-genom-090413-025610 . PubMed PMID: 24773320","DOI":"10.1146\/annurev-genom-090413-025610"},{"key":"8886_CR79","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ajmg.b.30668","volume":"147","author":"M Zetterberg","year":"2008","unstructured":"Zetterberg M, Landgren S, Andersson ME, Palm\u00e9r MS, Gustafson DR, Skoog I, Minthon L, Thelle DS, Wallin A, Bogdanovic N, Andreasen N, Blennow K, Zetterberg H (2008) Association of complement factor H Y402H gene polymorphism with Alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet 147:720\u2013726","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"8886_CR80","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neurobiolaging.2008.03.003","volume":"31","author":"I Fur Le","year":"2010","unstructured":"Le Fur I, Laumet G, Richard F, Fievet N, Berr C, Rouaud O, Delcourt C, Amouyel P, Lambert JC (2010) Association study of the CFH Y402H polymorphism with Alzheimer\u2019s disease. Neurobiol Aging 31:165\u2013166","journal-title":"Neurobiol Aging"},{"key":"8886_CR81","doi-asserted-by":"publisher","first-page":"1843.e9","DOI":"10.1016\/j.neurobiolaging.2011.12.036","volume":"33","author":"P Proitsi","year":"2012","unstructured":"Proitsi P, Lupton MK, Dudbridge F, Tsolaki M, Hamilton G, Daniilidou M, Pritchard M, Lord K, Martin BM, Johnson J, Craig D, Todd S, McGuinness B, Hollingworth P, Harold D, Kloszewska I, Soininen H, Mecocci P, Velas B, Gill M, Lawlor B, Rubinsztein DC, Brayne C, Passmore PA, Williams J, Lovestone S, Powell JF (2012) Alzheimer\u2019s disease and age-related macular degeneration have different genetic models for complement gene variation. Neurobiol Aging 33:1843.e9\u20131843.e17. doi: 10.1016\/j.neurobiolaging.2011.12.036","journal-title":"Neurobiol Aging"},{"key":"8886_CR82","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1479-7364-6-13","volume":"6","author":"MM Liu","year":"2012","unstructured":"Liu MM, Chan CC, Tuo J (2012) Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics. Hum Genomics 6:13. doi: 10.1186\/1479-7364-6-13","journal-title":"Hum Genomics"},{"key":"8886_CR83","doi-asserted-by":"crossref","first-page":"31315","DOI":"10.1074\/jbc.M805371200","volume":"283","author":"WJ Lukiw","year":"2008","unstructured":"Lukiw WJ, Zhao Y, Cui JG (2008) An NF-kB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283:31315\u201331322","journal-title":"J Biol Chem"},{"key":"8886_CR84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12035-012-8234-4","volume":"46","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ, Alexandrov PN (2012) Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer\u2019s disease (AD) brain. Mol Neurobiol 46:11\u201319","journal-title":"Mol Neurobiol"},{"key":"8886_CR85","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","volume":"107","author":"V Ambros","year":"2001","unstructured":"Ambros V (2001) microRNAs: tiny regulators with great potential. Cell 107:823\u2013826","journal-title":"Cell"},{"key":"8886_CR86","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294:853\u2013858","journal-title":"Science"},{"key":"8886_CR87","first-page":"365","volume":"3","author":"PN Alexandrov","year":"2012","unstructured":"Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ (2012) microRNA (miRNA) speciation in Alzheimer\u2019s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol 3:365\u2013373","journal-title":"Int J Biochem Mol Biol"},{"key":"8886_CR88","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","volume":"466","author":"H Guo","year":"2010","unstructured":"Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:835\u2013840","journal-title":"Nature"},{"key":"8886_CR89","first-page":"105","volume":"3","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN (2012) Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer\u2019s disease (AD) and in age-related macular degeneration (AMD). Int J Biochem Mol Biol 3:105\u2013116","journal-title":"Int J Biochem Mol Biol"},{"key":"8886_CR90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","volume":"29","author":"DH Anderson","year":"2010","unstructured":"Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Rickman CB, Bok D, Hageman GS, Johnson LV (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29:95\u2013112","journal-title":"Prog Retin Eye Res"},{"key":"8886_CR91","first-page":"242","volume":"5","author":"YL Quan","year":"2012","unstructured":"Quan YL, Zhou AY, Feng ZH (2012) Association between complementary factor H Y402H polymorphisms and age-related macular degeneration in Chinese: systematic review and meta-analysis. Int J Ophthalmol 5:242\u2013246","journal-title":"Int J Ophthalmol"},{"key":"8886_CR92","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ophtha.2010.06.040","volume":"118","author":"N Kondo","year":"2011","unstructured":"Kondo N, Bessho H, Honda S, Negi A (2011) Complement factor H Y402H variant and risk of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 118:339\u2013344","journal-title":"Ophthalmology"},{"key":"8886_CR93","first-page":"37","volume":"75","author":"VV Ermilov","year":"2013","unstructured":"Ermilov VV, Tiurenkov IN, Nesterova AA, Zagrebin VA (2013) Alzheimer\u2019s disease and geriatric eye diseases in the aspect of amyloid genesis. Arkh Patol 75:37\u201342","journal-title":"Arkh Patol"},{"key":"8886_CR94","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1038\/tp.2012.150","volume":"3","author":"S Frost","year":"2013","unstructured":"Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN, Group AR (2013) Retinal vascular biomarkers for early detection and monitoring of Alzheimer\u2019s disease. Transl Psychiatry 3:e233","journal-title":"Transl Psychiatry"},{"key":"8886_CR95","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.222551899","volume":"99","author":"JW Crabb","year":"2002","unstructured":"Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99:14682\u201314687","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8886_CR96","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.neurobiolaging.2013.11.026","volume":"35","author":"T Jiang","year":"2014","unstructured":"Jiang T, Yu JT, Zhu XC, Tan MS, Gu LZ, Zhang YD et al (2014) Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice. Neurobiol Aging 35:1243\u20131251","journal-title":"Neurobiol Aging"},{"key":"8886_CR97","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/emmm.201101084","volume":"4","author":"J Cai","year":"2012","unstructured":"Cai J, Qi X, Kociok N, Skosyrski S, Emilio A, Ruan Q, Han S, Liu L, Chen Z, Bowes Rickman C, Golde T, Grant MB, Saftig P, Serneels L, de Strooper B, Joussen AM, Boulton ME (2012) beta-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment. EMBO Mol Med 4:980\u2013991","journal-title":"EMBO Mol Med"},{"key":"8886_CR98","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314\u20131318","journal-title":"Science"},{"key":"8886_CR99","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, Tanzi RE (2013) Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78:631\u2013643","journal-title":"Neuron"},{"key":"8886_CR100","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1167\/iovs.12-10827","volume":"54","author":"JM Sivak","year":"2013","unstructured":"Sivak JM (2013) The aging eye: common degenerative mechanisms between the Alzheimer\u2019s brain and retinal disease. Invest Ophthalmol Vis Sci 54:871\u2013880","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8886_CR101","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archophthalmol.2009.30","volume":"127","author":"ML Baker","year":"2009","unstructured":"Baker ML, Wang JJ, Rogers S, Klein R, Kuller LH, Larsen EK, Wong TY (2009) Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study. Arch Ophthalmol 127:667\u2013673","journal-title":"Arch Ophthalmol"},{"key":"8886_CR102","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.ophtha.2012.04.026","volume":"119","author":"SJ Woo","year":"2012","unstructured":"Woo SJ, Park KH, Ahn J, Choe JY, Jeong H, Han JW, Kim TH, Kim KW (2012) Cognitive impairment in age-related macular degeneration and geographic atrophy. Ophthalmology 119:2094\u20132101","journal-title":"Ophthalmology"},{"key":"8886_CR103","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature08781","volume":"463","author":"A Raj","year":"2010","unstructured":"Raj A, Rifkin SA, Andersen E, van Oudenaarden A (2010) Variability in gene expression underlies incomplete penetrance. Nature 463:913\u2013918","journal-title":"Nature"},{"key":"8886_CR104","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11357-011-9260-2","volume":"34","author":"K Chiu","year":"2012","unstructured":"Chiu K, Chan TF, Wu A, Leung IY, So KF, Chang RC (2012) Neurodegeneration of the retina in mouse models of Alzheimer\u2019s disease: what can we learn from the retina? Age (Dordr) 34:633\u2013649","journal-title":"Age (Dordr)"},{"key":"8886_CR105","doi-asserted-by":"crossref","first-page":"1510.e7","DOI":"10.1016\/j.neurobiolaging.2013.12.007","volume":"35","author":"MW Logue","year":"2014","unstructured":"Logue MW, Schu M, Vardarajan BN, Farrell J, Lunetta KL, Jun G, Baldwin CT, Deangelis MM, Farrer LA (2014) A search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways. Neurobiol Aging 35:1510.e7\u20131510.e18","journal-title":"Neurobiol Aging"},{"key":"8886_CR106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-genom-090711-163825","volume":"13","author":"MV Olson","year":"2012","unstructured":"Olson MV (2012) Human genetic individuality. Annu Rev Genomics Hum Genet 13:1\u201327","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"8886_CR107","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.visres.2007.07.025","volume":"48","author":"JD Ding","year":"2008","unstructured":"Ding JD, Lin J, Mace BE, Herrmann R, Sullivan P, Bowes Rickman C (2008) Targeting age-related macular degeneration with Alzheimer\u2019s disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model. Vis Res 48:339\u2013345","journal-title":"Vis Res"},{"key":"8886_CR108","doi-asserted-by":"crossref","first-page":"E279","DOI":"10.1073\/pnas.1100901108","volume":"108","author":"JD Ding","year":"2011","unstructured":"Ding JD, Johnson LV, Herrmann R, Farsiu S, Smith SG, Groelle M, Mace BE, Sullivan P, Jamison JA, Kelly U, Harrabi O, Bollini SS, Dilley J, Kobayashi D, Kuang B, Li W, Pons J, Lin JC, Bowes Rickman C (2011) Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A 108:E279\u2013E287","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8886_CR109","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2014.01.004","volume":"563","author":"N Hu","year":"2014","unstructured":"Hu N, Tan MS, Sun L, Jiang T, Wang YL, Tan L, Zhang W, Yu JT, Tan L (2014) Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer\u2019s disease patients. Neurosci Lett 563:51\u201354","journal-title":"Neurosci Lett"},{"key":"8886_CR110","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00417-009-1060-3","volume":"247","author":"RM Dutescu","year":"2009","unstructured":"Dutescu RM, Li QX, Crowston J, Masters CL, Baird PN, Culvenor JG (2009) Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer\u2019s disease. Graefes Arch Clin Exp Ophthalmol 247:1213\u20131221","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-8886-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8886-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8886-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8886-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T20:08:17Z","timestamp":1565813297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-8886-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,10]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["8886"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-8886-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,10]]}}}